|
| Research progress of Xuebijing Injection in the treatment of sepsis |
| Hits 1580 Download times 1438 Received:March 16, 2019 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2019.07.05 |
| Key Words
sepsis;Xuebijing Injection;research progress |
| Author Name | Affiliation | | LIANG Qun | The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China | | GUAN Dixin | The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China | | CHE Sihua | Heilongjiang University of Traditional Chinese Medicine, Harbin 150040, China |
|
| Abstract
|
| Sepsis is a systemic inflammatory response syndrome caused by infectious factors,the essence of which is the body's response to infectious factors. Xuebijing Injection is a Chinese patent medicine preparation developed on the basis of Xuefu Zhuyu Decoction. It is a combination of traditional Chinese medicines such as safflower,Chuanxiong,Chishao,Angelica and Salvia. Its active ingredients include ligustrazine and safflower yellow. Pigment A,Danshensu and ferulic acid have the functions of dispelling poisonous evil,promoting blood circulation and removing phlegm and clearing meridians,regulating immune response,antagonizing endotoxin and improving microcirculation disorders,and are often used in the treatment of sepsis. This article will review the pharmacological effects of Xuebijing Injection and the mechanism of action in the treatment of sepsis. |
|
|
|
|
|
|
|
